NEXGEL To Report First Quarter 2026 Financial Results on May 15th
NEXGEL (NASDAQ:NXGL) will report first quarter 2026 financial results for the period ended March 31, 2026 on Friday, May 15, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
NEXGEL (NASDAQ:NXGL) will report first quarter 2026 financial results for the period ended March 31, 2026 on Friday, May 15, 2026.
Management will host a conference call at 12:00 P.M. ET, with phone and webcast access plus replay options.
Details
News Market Reaction – NXGL
On May 12, the day this news came out, NXGL closed 4.13% below the previous close.
Data tracked by StockTitan Argus for the May 12 session.
Key Figures
- Earnings call date
- May 15, 2026
- First quarter 2026 results release and conference call
- Earnings call time
- 12:00 P.M. ET
- First quarter 2026 conference call start time
- Replay end date
- May 29, 2026
- Conference call replay available through this date
- Replay access code
- 11161819
- Code required to access conference call replay
Previous Earnings date Reports
-
Announced Q4 and full-year 2025 results date and earnings call details.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Management Will Host a Conference Call at 12:00 P.M. ET on the Same Day
LANGHORNE, Pa., May 12, 2026 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced it will report its financial results for the first quarter 2026 ended March 31, 2026, on Friday, May 15, 2026. Following the release of its financial results, the Company will host a conference call at 12:00 P.M. ET on the same day.
First Quarter 2026 Financial Results Conference Call:
Date: May 15, 2026
Time: 12:00 P.M. ET
Live Call: 1-800-267-6316 (U.S. Toll Free) or 1-203-518-9783 (International)
Webcast: Events and Presentations
For interested individuals unable to join the conference call, a replay will be available through May 29, 2026, by dialing 1-844-512-2921 (U.S. Toll Free) or 1-412-317-6671 (International). Participants must use the following code to access the replay of the call: 11161819. An archived version of the webcast will also be available for 90 days.
About NEXGEL, Inc.
NEXGEL is a leading provider of healthcare, beauty, and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications. Based in Langhorne, Pa., the Company has developed and manufactured electron-beam, cross-linked hydrogels for over two decades. NEXGEL brands include SilverSeal®, Hexagels®, Turfguard®, Kenkoderm® and Silly George®. Additionally, NEXGEL has strategic contract manufacturing relationships with leading consumer healthcare companies.
Investor Contact:
Valter Pinto, Managing Director
KCSA Strategic Communications
212.896.1254
Nexgel@KCSA.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.